摘要
目的研究如何对剖宫产瘢痕妊娠(CSP)患者进行药物保守治疗。方法 1例CSP合并子宫卒中患者,在手术治疗无法开展的情况下,笔者探讨如何针对血清β-HCG>20 000IU/L的患者制订药物保守治疗方案并预防产生毒副作用。结果患者经2次子宫动脉栓塞+MTX50mg子宫动脉灌注,3次MTX50mg宫颈注射联合口服米非司酮保守治疗后,血清β-HCG转阴,无不良反应发生,保守治疗成功。结论临床药师对CSP患者的药物保守治疗开展全程药学监护,对保障患者用药的安全、有效具有较大帮助和促进作用。
Objective To study the conservative treatment for cesarean scar pregnancy （CSP） with proper medications . Methods One case of CSP with uterine apoplexy was reported .Medication regimens were illustrated as the conservative treat-ments for the patient with β-HCG〉20 000 IU/L ,in whom surgery was contraindicated .Results After two times of uterine artery embolization and chemotherapy （MTX50 mg） ,followed by three times of MTX50 mg cervical injection combined with oral mifepristone ,serumβ-HCG dropped to normal level and no adverse reactions were observed .Conclusion Clinical pharma-cists could strengthen the safety and effectiveness of rational drug use by participating in the integrated pharmacy care .
出处
《药学实践杂志》
CAS
2016年第6期552-555,共4页
Journal of Pharmaceutical Practice
